Allergan PLC (NYSE:AGN)

The financial performance from 2015 to 2019 is characterized by significant volatility and a persistent divergence between operational cash flow proxies and bottom-line profitability. While EBITDA remained positive for most of the period, the entity experienced consistent losses at the EBIT, EBT, and Net Income levels for the majority of the analyzed timeframe.

EBITDA Trends

EBITDA demonstrated a fluctuating trajectory, peaking in 2016 at 5,094,600 thousand USD. A sharp decline occurred in 2017, where the figure turned negative to -1,922,200 thousand USD. However, a recovery phase followed, with EBITDA returning to positive territory in 2018 and increasing further to 1,725,400 thousand USD by 2019.

Operational Divergence and Non-Cash Charges

A substantial gap is observed between EBITDA and EBIT across all five years. For instance, in 2019, while EBITDA was positive at 1,725,400 thousand USD, EBIT remained negative at -4,335,700 thousand USD. This consistent disparity indicates that high depreciation and amortization expenses are significantly weighing down operational results, transforming positive cash-basis operational performance into accounting losses.

Earnings Before Tax (EBT) and EBIT Stability

Both EBIT and EBT remained consistently negative throughout the period, with the exception of a slight narrowing of losses in 2016. The most severe contraction occurred in 2017, with EBT reaching its lowest point at -10,386,400 thousand USD. From 2018 to 2019, a gradual upward trend is noted, as EBT losses reduced to -5,118,700 thousand USD, suggesting a slow improvement in pre-tax financial positioning.

Net Income Volatility

Net income attributable to shareholders showed the most extreme variance. After a significant spike to 14,973,400 thousand USD in 2016, the metric shifted to a sustained loss position starting in 2017. Net losses deepened from -4,125,500 thousand USD in 2017 to -5,271,000 thousand USD by 2019, indicating that the recovery observed in EBITDA has not yet translated into bottom-line profitability.

The financial period between 2015 and 2019 is characterized by significant volatility in both enterprise valuation and operational profitability, resulting in erratic fluctuations in the valuation multiple.

Enterprise Value Trends

A sustained downward trend in enterprise value is observed from 2015 through 2018, with the value decreasing from 164.2 billion US$ to 68.2 billion US$. This represents a substantial contraction in the total market valuation of the entity over three years. A reversal occurred in 2019, where the enterprise value increased to 81.9 billion US$.

EBITDA Performance

Operational earnings exhibited extreme instability during the analyzed timeframe. EBITDA grew from 2.76 billion US$ in 2015 to a peak of 5.09 billion US$ in 2016, before experiencing a severe decline to a negative 1.92 billion US$ in 2017. A recovery trend followed, with earnings returning to positive territory at 802.9 million US$ in 2018 and further improving to 1.73 billion US$ in 2019.

EV/EBITDA Ratio Analysis

The valuation multiple reflects the volatility of the underlying earnings and valuation metrics. The ratio decreased significantly from 59.52 in 2015 to 20.95 in 2016, driven by a strong increase in EBITDA. The ratio was not calculable in 2017 due to negative earnings. In 2018, the ratio spiked to a period high of 84.90, as the enterprise value remained high relative to a very low earnings base. By 2019, the ratio moderated to 47.47, reflecting a simultaneous increase in both the enterprise value and operational profitability.